{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T08:20:20Z","timestamp":1773303620025,"version":"3.50.1"},"update-to":[{"DOI":"10.1002\/14651858.cd006686","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2008,1,23]],"date-time":"2008-01-23T00:00:00Z","timestamp":1201046400000}}],"reference-count":20,"publisher":"Wiley","issue":"7","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd006686.pub2","type":"journal-article","created":{"date-parts":[[2008,2,5]],"date-time":"2008-02-05T20:11:33Z","timestamp":1202242293000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Bradykinin beta-2 receptor antagonists for acute traumatic brain injury"],"prefix":"10.1002","volume":"2010","author":[{"given":"Katharine","family":"Ker","sequence":"first","affiliation":[{"name":"London School of Hygiene & Tropical Medicine; Cochrane Injuries Group; Room 280, North Courtyard Keppel Street London UK WC1E 7HT"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Blackhall","sequence":"additional","affiliation":[{"name":"London School of Hygiene & Tropical Medicine; Cochrane Injuries Group; Room 280, North Courtyard Keppel Street London UK WC1E 7HT"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,1,23]]},"reference":[{"key":"10.1002\/14651858.CD006686.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/1745-6215-10-109","article-title":"The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury","volume":"10","author":"Shakur","year":"2009","journal-title":"Trials"},{"issue":"6","key":"10.1002\/14651858.CD006686.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1089\/neu.1999.16.431","article-title":"Effects of the bradykinin antagonist Bradycor (deltibant, CP-1027) in severe traumatic brain injury: results of a multi-center, randomized, placebo-controlled trial. American Brain Injury Consortium Study Group","volume":"16","author":"Marmarou","year":"1999","journal-title":"Journal of Neurotrauma"},{"issue":"12","key":"10.1002\/14651858.CD006686.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1089\/neu.2005.22.1444","article-title":"A single dose, three-arm, placebo-controlled, phase I study of the bradykinin B2 receptor antagonist Anatibant (LF16-0687Ms) in patients with severe traumatic brain injury","volume":"22","author":"Marmarou","year":"2005","journal-title":"Journal of Neurotrauma"},{"issue":"8","key":"10.1002\/14651858.CD006686.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s007010050181","article-title":"Traumatic brain contusions: a clinical role for the kinin antagonist CP-0127","volume":"140","author":"Narotam","year":"1998","journal-title":"Acta Neurochirurgica"},{"key":"10.1002\/14651858.CD006686.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1528-1157.44.s10.3.x","article-title":"The epidemiology of traumatic brain injury: a review","volume":"10","author":"Bruns","year":"2003","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD006686.pub2-BIB0006|cit6","unstructured":"National Center for Injury Prevention and Control Traumatic brain injury - factsheet CDC - www.cdc.gov\/ncipc\/tbi 2006"},{"key":"10.1002\/14651858.CD006686.pub2-BIB0007|cit7","first-page":"27","article-title":"Bradykinin and neuronal injury","volume":"9 Suppl 1","author":"Francel","year":"1992","journal-title":"Journal of Neurotrauma"},{"key":"10.1002\/14651858.CD006686.pub2-BIB0008|cit8","doi-asserted-by":"crossref","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008] The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org","DOI":"10.1002\/9780470712184"},{"issue":"4","key":"10.1002\/14651858.CD006686.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1097\/01.ta.0000234722.98537.01","article-title":"Bradykinin B2 receptor antagonism with LF 18-1505T reduces brain edema and improves neurological outcome after closed head trauma in rats","volume":"61","author":"Ivashkova","year":"2006","journal-title":"Journal of Trauma"},{"issue":"8","key":"10.1002\/14651858.CD006686.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1089\/089771502320317104","article-title":"LF 16-0687 Ms, a bradykinin B2 receptor antagonist, reduces brain edema and improves long-term neurological function recovery after closed head trauma in rats","volume":"19","author":"Kaplanski","year":"2002","journal-title":"Journal of Neurotrauma"},{"key":"10.1002\/14651858.CD006686.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0006-8993(96)01000-1","article-title":"Role of activation of bradykinin B2 receptors in disruption of the blood-brain barrier during acute hypertension","volume":"738","author":"Mayhan","year":"1996","journal-title":"Brain Research"},{"issue":"7931","key":"10.1002\/14651858.CD006686.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0140-6736(75)92893-7","article-title":"Patients with head injury who talk and die","volume":"2","author":"Reilly","year":"1975","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD006686.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"853","DOI":"10.3171\/jns.2000.92.5.0853","article-title":"Significant reduction in brain swelling by administration of nonpeptide kinin B2 receptor antagonist LF 16-0687Ms after controlled cortical impact injury in rats","volume":"92","author":"Stover","year":"2000","journal-title":"Journal of Neurosurgery"},{"issue":"3","key":"10.1002\/14651858.CD006686.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00701-005-0651-y","article-title":"A systematic review of brain injury epidemiology in Europe","volume":"148","author":"Tagliaferri","year":"2006","journal-title":"Acta Neurochirurgica"},{"issue":"7250","key":"10.1002\/14651858.CD006686.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1136\/bmj.320.7250.1631","article-title":"Disability in young people and adults one year after head injury: prospective cohort study","volume":"320","author":"Thornhill","year":"2000","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD006686.pub2-BIB0016|cit16","first-page":"200","article-title":"Prevention and treatment of secondary brain damage. Clinical aspects","volume":"100","author":"Unterberg","year":"1991","journal-title":"Chest"},{"key":"10.1002\/14651858.CD006686.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.neuroscience.2004.06.046","article-title":"Edema and brain trauma","volume":"129","author":"Unterberg","year":"2004","journal-title":"Neuroscience"},{"issue":"6","key":"10.1002\/14651858.CD006686.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1097\/01.CCM.0000166890.93559.2D","article-title":"Primer on medical management of severe brain injury","volume":"33","author":"Vincent","year":"2005","journal-title":"Critical Care Medicine"},{"key":"10.1002\/14651858.CD006686.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1136\/jnnp.2005.078246","article-title":"Disability in young people and adults after head injury: 5 - 7 year follow up of a prospective cohort","volume":"77","author":"Whitnall","year":"2006","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD006686.pub2-BIB0020|cit20","unstructured":"Neurological Disorders - Public Health Challenges WHO 2006"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD006686.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:02:46Z","timestamp":1757894566000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD006686.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Injuries Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2008,1,23]]},"references-count":20,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2010,7]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006686.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,23]]}}}